Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Barreiro

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Antiviral Therapy|September 13, 2005
Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis CMarina Núnez, Nuria Camino, Belén Ramos, et al.
AIDS (London, England)|March 31, 2017
HIV type 2 epidemic in Spain: challenges and missing opportunitiesCarmen de Mendoza, Teresa Cabezas, Estrella Caballero, et al.
Iscience|September 18, 2023
Genetic signature detected in T cell receptors from patients with severe COVID-19Manuel Corpas, Carmen de Mendoza, Víctor Moreno-Torres, et al.
Journal of Clinical Microbiology|January 12, 2022
A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered CohortPablo Barreiro, Juan Carlos Sanz, Jesús San Román, et al.
Age and Ageing|May 4, 2021
The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS studyFrancisco Javier Candel, Pablo Barreiro, Jesús San Román, et al.
Gerontology|June 2, 2022
Cross-Sectional Analysis of Risk Factors for Outbreak of COVID-19 in Nursing Homes for Older Adults in the Community of MadridJesús San Román, Francisco J Candel, María Del Mar Carretero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2010
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIVJose Medrano, Karin Neukam, Norma Rallón, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2007
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral loadCarlo Torti, Giuseppe Lapadula, Pablo Barreiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2011
Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis CNorma I Rallón, Judit Morello, Pablo Labarga, et al.
AIDS (London, England)|April 2, 2005
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosineAna Barrios, Ana Rendón, Eugenia Negredo, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Antiviral Therapy|September 13, 2005
Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis CMarina Núnez, Nuria Camino, Belén Ramos, et al.
AIDS (London, England)|March 31, 2017
HIV type 2 epidemic in Spain: challenges and missing opportunitiesCarmen de Mendoza, Teresa Cabezas, Estrella Caballero, et al.
Iscience|September 18, 2023
Genetic signature detected in T cell receptors from patients with severe COVID-19Manuel Corpas, Carmen de Mendoza, Víctor Moreno-Torres, et al.
Journal of Clinical Microbiology|January 12, 2022
A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered CohortPablo Barreiro, Juan Carlos Sanz, Jesús San Román, et al.
Age and Ageing|May 4, 2021
The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS studyFrancisco Javier Candel, Pablo Barreiro, Jesús San Román, et al.
Gerontology|June 2, 2022
Cross-Sectional Analysis of Risk Factors for Outbreak of COVID-19 in Nursing Homes for Older Adults in the Community of MadridJesús San Román, Francisco J Candel, María Del Mar Carretero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2010
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIVJose Medrano, Karin Neukam, Norma Rallón, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2007
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral loadCarlo Torti, Giuseppe Lapadula, Pablo Barreiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2011
Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis CNorma I Rallón, Judit Morello, Pablo Labarga, et al.
AIDS (London, England)|April 2, 2005
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosineAna Barrios, Ana Rendón, Eugenia Negredo, et al.
Pageof 22